Review Article
Volume 7 Issue 2 - 2020
Non Alcoholic Fatty Liver Disease: Participation of Genetic, Metabolic, Biochemical and Immunologic Factors in the Pathogenesis
Tania Beatriz Romero-Adrián*
Graduate Studies in Immunology, Institute of Biological Research, Faculty of Medicine, University of Zulia, Venezuela
*Corresponding Author: Tania Beatriz Romero- Adrián, Graduate Studies in Immunology, Institute of Biological Research, Faculty of Medicine, University of Zulia, Venezuela.
Received: September 20, 2019; Published: January 09, 2020




Abstract

Non Alcoholic Fatty Liver Disease (NAFLD) occurs as a result of the accumulation of free fatty acids (FFA) y Triglycerides (TG) in the cytoplasm of hepatocytes. There are a correlation between NAFLD and risk factors as obesity, diabetes, dyslipidemia, high blood pressure (HBP), and other conditions related to lifestyle. It is considered a public health problem and studies have demonstrated that a high percentage (90 to 100%) of the obese patients present some degree of NAFLD. It is estimated that by 2030 around 38% of the world population will have overweight and another 20% will be obese. In the pathogenesis of NAFLD participates metabolic, biochemical and immunologic events with continuous stimulation. The establishment, development and progression of NAFLD is due to the accumulation of reactive oxygen species (ROS) as well as inflammation resulting from the up regulated release of pro-inflammatory cytokines from hepatocytes. Investigations appoint that the augment of proinflammatory/profibrotic cytokines and decrease of anti-inflammatory/anti-fibrotic determine an imbalance which leads to the hepatic injury.

In NAFLD the alteration of lipid and carbohydrate metabolism that leads to the accumulation of liver fat is the initial stimulus; the imbalance of cytokines and oxidant/anti-oxidant factors, ROS accumulation and the mobilization of immune cells, oxidative stress, lipotoxicity, apoptosis and fibrosis are processes lead to imminent tissue damage.

Keywords: NAFLD; ROS (Reactive Oxygen Species); Imbalance

References

  1. Bugianesi E., et al. “Expanding the natural history of nonalcoholic steatohepatitis: From cryptogenic cirrhosis to hepatocellular carcinoma”. Gastroenterology 123.1 (2002): 134-140.
  2. Bellentani S., et al. “Epidemiology of non- alcoholic fatty liver disease”. Digital Distribution 28.1 (2010): 155-161.
  3. Hruby A and Hu FB. “The Epidemiology of Obesity: A Big Picture”. Pharmacoeconomics 33.7 (2015): 673-689.
  4. Moreno-Sanchez D. “Epidemiology and natural history of primary nonalcoholic fatty liver disease”. Gastroenterology and Hepatology 29.4 (2006): 244-254.
  5. Caballeria LL., et al. “¿Qué debería saber el médico de familia sobre? Esteatosis hepática: diagnóstico y seguimiento”. FMC 24.7 (2017): 378-389.
  6. Martín V., et al. “Etiopatogenia, diagnóstico y tratamiento de la enfermedad del hígado graso no alcohólica”. Revista Espanola de Enfermedades Digestivas 105.7 (2013): 409-420.
  7. Solis-Herruzo JA, Solis-Muñoz P. “Genetic factors in non-alcoholic fatty liver disease”. Revista Espanola de Enfermedades Digestivas 100.4 (2008): 195-201.
  8. Zoller V., et al. “TRAIL (TNF-related apoptosis-inducing ligand) inhibits human adipocyte differentiation via caspase-mediated downregulation of adipogenic transcription factors”. Cell Death and Disease 7.10 (2016): e2412.
  9. Zain SM., et al. “A multi-ethnic study of a PNPLA3 gene variant and its association with disease severity in non-alcoholic fatty liver disease”. Human Genetics 131.7 (2012): 1145-1152.
  10. Daly AK., et al. “Genetic determinants of susceptibility and severity in nonalcoholic fatty liver disease”. Expert Review of Gastroenterology and Hepatology 5.2 (2011): 253-263.
  11. Lakhani HV., et al. “Phenotypic Alteration of Hepatocytes in Non-Alcoholic Fatty Liver Disease”. International Journal of Medical Sciences 15.14 (2018): 1591-1599.
  12. Neuman MG., et al. “Biomarkers in nonalcoholic fatty liver disease”. Canadian Journal of Gastroenterology and Hepatology 28.11 (2014): 607-618.
  13. Cawthorn WP and Sethi JK. “TNF-alpha and adipocyte biology”. FEBS Letters 582.1 (2008): 117-131.
  14. Kern PA., et al. “Adipose tissue tumor necrosis factor and interleukin-6 expression in human obesity and insulin resistance”. American Journal of Physiology-Endocrinology and Metabolism 280.5 (2001): E745-751.
  15. Wood IS., et al. “The pro-inflammatory cytokine IL-18 is expressed in human adipose tissue and strongly upregulated by TNFalpha in human adipocytes”. Biochemical and Biophysical Research Communications 337.2 (2005): 422-429.
  16. Solís Herruzo JA., et al. “Non-alcoholic fatty liver disease. From insulin resistance to mitochondrial dysfunction”. Revista Espanola de Enfermedades Digestivas 98.11 (2006): 844-874.
  17. Day CP and James OF. “Steatohepatitis: a tale of two “hits”?”. Gastroenterology 114.4 (1998): 842-845.
  18. Das SK and Balakrishnan V. “Role of cytokines in the pathogenesis of non-alcoholic Fatty liver disease”. Indian Journal of Clinical Biochemistry 26.2 (2011): 202-209.
  19. Paquissi FC. “Immune Imbalances in Non-Alcoholic Fatty Liver Disease: From General Biomarkers and Neutrophils to Interleukin-17 Axis Activation and New Therapeutic Targets”. Frontiers in Immunology.7 (2016): 490.
  20. Medina J and Moreno-Otero R. “Pathophysiological basis for antioxidant therapy in chronic liver disease”. Drugs 65.17 (2005): 2445-2461.
  21. Majano PL., et al. “Inducible nitric oxide synthase expression in chronic viral hepatitis. Evidence for a virus-induced gene upregulation”. Journal of Clinical Investigation 101.7 (1998): 1343-1352.
  22. García-Monzón C., et al. “Intrahepatic accumulation of nitrotyrosine in chronic viral hepatitis is associated with histological severity of liver disease”. Journal of Hepatology 32.2 (2000): 331-338.
  23. Carter-Kent C., et al. “Cytokines in the pathogenesis of fatty liver and disease progression to steatohepatitis: Implications for treatment”. The American Journal of Gastroenterology 103.4 (2008): 1036-1042.
  24. Sanz-Cameno P., et al. “Enhanced intrahepatic inducible nitric oxide synthase expression and nitrotyrosine accumulation in primary biliary cirrhosis and autoimmune hepatitis”. Journal of Hepatology 37.6 (2002): 723-729.
  25. Marino L and Jornayvaz FR. “Endocrine causes of nonalcoholic fatty liver disease”. World Journal of Gastroenterology 21.39 (2015): 11053-11076
  26. Romero-Adrián TB. “Obesity: Role of tumor necrosis factor-α, and other adipocytokines involved in the chronic inflammation and the Immune and metabolic dysregulation”. EC Gastroenterology and Digestive System 6.8 (2019): 626-632.
Citation: Tania Beatriz Romero-Adrián. “Non Alcoholic Fatty Liver Disease: Participation of Genetic, Metabolic, Biochemical and Immunologic Factors in the Pathogenesis”. EC Gastroenterology and Digestive System 7.2 (2020): 01-04.

PubMed Indexed Article


EC Pharmacology and Toxicology
LC-UV-MS and MS/MS Characterize Glutathione Reactivity with Different Isomers (2,2' and 2,4' vs. 4,4') of Methylene Diphenyl-Diisocyanate.

PMID: 31143884 [PubMed]

PMCID: PMC6536005


EC Pharmacology and Toxicology
Alzheimer's Pathogenesis, Metal-Mediated Redox Stress, and Potential Nanotheranostics.

PMID: 31565701 [PubMed]

PMCID: PMC6764777


EC Neurology
Differences in Rate of Cognitive Decline and Caregiver Burden between Alzheimer's Disease and Vascular Dementia: a Retrospective Study.

PMID: 27747317 [PubMed]

PMCID: PMC5065347


EC Pharmacology and Toxicology
Will Blockchain Technology Transform Healthcare and Biomedical Sciences?

PMID: 31460519 [PubMed]

PMCID: PMC6711478


EC Pharmacology and Toxicology
Is it a Prime Time for AI-powered Virtual Drug Screening?

PMID: 30215059 [PubMed]

PMCID: PMC6133253


EC Psychology and Psychiatry
Analysis of Evidence for the Combination of Pro-dopamine Regulator (KB220PAM) and Naltrexone to Prevent Opioid Use Disorder Relapse.

PMID: 30417173 [PubMed]

PMCID: PMC6226033


EC Anaesthesia
Arrest Under Anesthesia - What was the Culprit? A Case Report.

PMID: 30264037 [PubMed]

PMCID: PMC6155992


EC Orthopaedics
Distraction Implantation. A New Technique in Total Joint Arthroplasty and Direct Skeletal Attachment.

PMID: 30198026 [PubMed]

PMCID: PMC6124505


EC Pulmonology and Respiratory Medicine
Prevalence and factors associated with self-reported chronic obstructive pulmonary disease among adults aged 40-79: the National Health and Nutrition Examination Survey (NHANES) 2007-2012.

PMID: 30294723 [PubMed]

PMCID: PMC6169793


EC Dental Science
Important Dental Fiber-Reinforced Composite Molding Compound Breakthroughs

PMID: 29285526 [PubMed]

PMCID: PMC5743211


EC Microbiology
Prevalence of Intestinal Parasites Among HIV Infected and HIV Uninfected Patients Treated at the 1o De Maio Health Centre in Maputo, Mozambique

PMID: 29911204 [PubMed]

PMCID: PMC5999047


EC Microbiology
Macrophages and the Viral Dissemination Super Highway

PMID: 26949751 [PubMed]

PMCID: PMC4774560


EC Microbiology
The Microbiome, Antibiotics, and Health of the Pediatric Population.

PMID: 27390782 [PubMed]

PMCID: PMC4933318


EC Microbiology
Reactive Oxygen Species in HIV Infection

PMID: 28580453 [PubMed]

PMCID: PMC5450819


EC Microbiology
A Review of the CD4 T Cell Contribution to Lung Infection, Inflammation and Repair with a Focus on Wheeze and Asthma in the Pediatric Population

PMID: 26280024 [PubMed]

PMCID: PMC4533840


EC Neurology
Identifying Key Symptoms Differentiating Myalgic Encephalomyelitis and Chronic Fatigue Syndrome from Multiple Sclerosis

PMID: 28066845 [PubMed]

PMCID: PMC5214344


EC Pharmacology and Toxicology
Paradigm Shift is the Normal State of Pharmacology

PMID: 28936490 [PubMed]

PMCID: PMC5604476


EC Neurology
Examining those Meeting IOM Criteria Versus IOM Plus Fibromyalgia

PMID: 28713879 [PubMed]

PMCID: PMC5510658


EC Neurology
Unilateral Frontosphenoid Craniosynostosis: Case Report and a Review of the Literature

PMID: 28133641 [PubMed]

PMCID: PMC5267489


EC Ophthalmology
OCT-Angiography for Non-Invasive Monitoring of Neuronal and Vascular Structure in Mouse Retina: Implication for Characterization of Retinal Neurovascular Coupling

PMID: 29333536 [PubMed]

PMCID: PMC5766278


EC Neurology
Longer Duration of Downslope Treadmill Walking Induces Depression of H-Reflexes Measured during Standing and Walking.

PMID: 31032493 [PubMed]

PMCID: PMC6483108


EC Microbiology
Onchocerciasis in Mozambique: An Unknown Condition for Health Professionals.

PMID: 30957099 [PubMed]

PMCID: PMC6448571


EC Nutrition
Food Insecurity among Households with and without Podoconiosis in East and West Gojjam, Ethiopia.

PMID: 30101228 [PubMed]

PMCID: PMC6086333


EC Ophthalmology
REVIEW. +2 to +3 D. Reading Glasses to Prevent Myopia.

PMID: 31080964 [PubMed]

PMCID: PMC6508883


EC Gynaecology
Biomechanical Mapping of the Female Pelvic Floor: Uterine Prolapse Versus Normal Conditions.

PMID: 31093608 [PubMed]

PMCID: PMC6513001


EC Dental Science
Fiber-Reinforced Composites: A Breakthrough in Practical Clinical Applications with Advanced Wear Resistance for Dental Materials.

PMID: 31552397 [PubMed]

PMCID: PMC6758937


EC Microbiology
Neurocysticercosis in Child Bearing Women: An Overlooked Condition in Mozambique and a Potentially Missed Diagnosis in Women Presenting with Eclampsia.

PMID: 31681909 [PubMed]

PMCID: PMC6824723


EC Microbiology
Molecular Detection of Leptospira spp. in Rodents Trapped in the Mozambique Island City, Nampula Province, Mozambique.

PMID: 31681910 [PubMed]

PMCID: PMC6824726


EC Neurology
Endoplasmic Reticulum-Mitochondrial Cross-Talk in Neurodegenerative and Eye Diseases.

PMID: 31528859 [PubMed]

PMCID: PMC6746603


EC Psychology and Psychiatry
Can Chronic Consumption of Caffeine by Increasing D2/D3 Receptors Offer Benefit to Carriers of the DRD2 A1 Allele in Cocaine Abuse?

PMID: 31276119 [PubMed]

PMCID: PMC6604646


EC Anaesthesia
Real Time Locating Systems and sustainability of Perioperative Efficiency of Anesthesiologists.

PMID: 31406965 [PubMed]

PMCID: PMC6690616


EC Pharmacology and Toxicology
A Pilot STEM Curriculum Designed to Teach High School Students Concepts in Biochemical Engineering and Pharmacology.

PMID: 31517314 [PubMed]

PMCID: PMC6741290


EC Pharmacology and Toxicology
Toxic Mechanisms Underlying Motor Activity Changes Induced by a Mixture of Lead, Arsenic and Manganese.

PMID: 31633124 [PubMed]

PMCID: PMC6800226


EC Neurology
Research Volunteers' Attitudes Toward Chronic Fatigue Syndrome and Myalgic Encephalomyelitis.

PMID: 29662969 [PubMed]

PMCID: PMC5898812


EC Pharmacology and Toxicology
Hyperbaric Oxygen Therapy for Alzheimer's Disease.

PMID: 30215058 [PubMed]

PMCID: PMC6133268


News and Events


January Issue Release

We Always feel pleasure to share our updates with you all. Here, notifying you that we have successfully released January issue for the respective journals and can be viewed in the current issue pages.

Submission Deadline for March Issue

E-Cronicon delightfully welcome all the authors around the globe for an effective collaboration with an article submission for the March issue of respective journals. Submissions are accepted on/before January 31, 2020.

Certificate of Publication

E-Cronicon honours with a "Publication Certificate" to the corresponding author by including the names of co-authors as a token of appreciation for publishing the work with our respective journals.

Best Article of the Issue

Editors of respective journals will always be very much interested in electing one Best Article after each issue release. The authors of the selected article will be honored with a "Best Article of the Issue" certificate.

Certifying for Review

E-Cronicon certify the Editors for their first review done towards assigned article of the respective journals.

Latest Articles

Latest articles will be updated immediately in the articles in press page of the respective journals.

Immediate Assistance

Prime moto of this team is to clarify all the queries without any delay or hesitation in order to avoid the inconvenience. For an immediate assistance on your queries please don't hesitate to drop an email to editor@ecronicon.uk